Phase I/II Study of SCTB39G in Advanced Solid Tumours

Clinical trial NCT07077252 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07077252
Sponsor: Sinocelltech Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2025-07-28
Primary completion: 2027-09-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.